Vanda says anxiety drug failed main goal of late-stage study, puts program on hold

Vanda Pharmaceuticals said on Wednesday its experimental drug for social anxiety disorder ​failed the main goal of a ‌late-stage study, prompting the company to put the program on hold pending further...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。